Design, Synthesis, and Characterization of a Dual Modality Positron Emission Tomography and Fluorescence Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging-Reference-Cited by-同舟云学术

Design, Synthesis, and Characterization of a Dual Modality Positron Emission Tomography and Fluorescence Imaging Agent for Monoclonal Antibody Tumor-Targeted Imaging

Published:2007-08-29 Issue:19 Volume:50 Page:4759-4765
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Xu Heng¹,Baidoo Kwamena¹,Gunn Andrew J.¹,Boswell C. Andrew¹,Milenic Diane E.¹,Choyke Peter L.¹,Brechbiel Martin W.¹

Affiliation:

1. Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892-1088, and Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892-1088

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm070657w

Reference20 articles.

1. Multimodality Imaging

2. PET/CT: Form and Function

3. Molecular Imaging in the Clinical Arena

4. Fluorescently Detectable Magnetic Resonance Imaging Agents

5. Design and Synthesis of a Bimodal Target-Specific Contrast Agent for Angiogenesis

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Medical and Biological Applications of Indium(III) Complexes;Chemistry Africa;2024-02-10

2. Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications;Cancers;2022-03-23

3. Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors;Bioconjugate Chemistry;2022-03-01

4. Transpathology: molecular imaging-based pathology;European Journal of Nuclear Medicine and Molecular Imaging;2021-02-13

5. Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent;Chemical Communications;2021